Company intelligence / Profile preview

L.A.M.A

Basel, Basel-Stadt, Switzerland

Ownership: Private
Development stage: Other

Overview

LAMA Therapeutics is a Swiss biotechnology company focused on developing a novel class of protein therapeutics using its proprietary synthetic biology platform. The company leverages advanced protein engineering to design molecules that can modulate complex biological pathways with high specificity and potency. Its technology aims to address unmet medical needs by creating next-generation biologics that overcome the limitations of traditional antibody-based therapies. Currently in the pre-clinical stage, LAMA Therapeutics is advancing a pipeline of programs primarily targeting indications in oncology and immunology.

Therapeutic areas: OncologyImmunology
Modalities: ProteinRecombinant proteinSynthetic biology
Industry: Biotech

Beyond the preview

Go deeper on L.A.M.A.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on L.A.M.A.

Explore the full profile